DIANA GOLDBERG: Open Payments
NPI 1164902003 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 11 payments from 5 companies in 2025. Trend: 2023 $449 · 2024 $191 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $365 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $64 |
| UROGEN PHARMA, INC. | 1 | $32 |
| Blue Earth Diagnostics | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
Products named: RYBREVANT, ERLEADA, PYLARIFY, JELMYTO, POSLUMA, ORGOVYX.
Industry payments across NY — which companies pay providers there.
